Single Ascending Dose Study of PBI-4547 in Healthy Subjects

NCT04068259 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped PK data from first 3 cohorts does not support study continuation.There was no safety concerns

Conditions

Healthy Subjects

Interventions

DRUG: PBI-4547
OTHER: Placebo

Sponsor

Liminal BioSciences Ltd.

Collaborators

[object Object]